Sir,

There is evidence of possible association between Hepatitis C virus and lung cancer.\[[@ref1][@ref2]\] We present a case to emphasize on this association.

A 29-year-old, non smoker was admitted with the chief complaints of chest pain and breathlessness for 2 months and hemoptysis for 1 month. He was a never smoker and didn't have significant exposure to second-hand tobacco smoke. He had no family history of lung cancer, but had received 3 units of blood transfusions 9 years back. Routine investigations except for liver function tests were within normal limits. His serum bilirubin was 3 mg/dl, SGOT 65 U/L, SGPT 52 U/L and alkaline phosphatase 240 U/L. Anti HCV antibodies were detected through ELISA method. His HCV genotype was type 1. HCV quantitative report was 21, 90,000 IU/ml HCV RNA. He tested negative by ELISA for HIV, Ig M Anti-HAV, Ig G Anti- HAV and HBsAg. Sputum for AFB smear was negative and PPD showed induration of 3 mm after 72 h.

Chest X ray PA showed a mass lesion in the left middle zone \[[Figure 1](#F1){ref-type="fig"}\]. Contrast enhanced CT scan (CECT) of thorax revealed a heterogeneously enhancing mass lesion with enhancement of 68 Hounsfield Units in the left upper lobe, abutting the chest wall \[[Figure 2](#F2){ref-type="fig"}\]. CT-guided biopsy of lung mass and histopathology revealed an adenocarcinoma \[[Figure 3](#F3){ref-type="fig"}\]. Immunohistochemistry revealed tumor positive for TTF-1. CECT of neck and abdomen were negative, thus ruling out a primary from these regions. The diagnosis of adenocarcinoma lung with Hepatitis C seropositivity was made.
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![A CECT Thorax showing left collapse with a mass lesion in the anterior segment of left upper lobe](SAJC-2-86a-g002){#F2}

![A high power micrograph of a section through the lung mass showing cancer cells with abnormally large nuclei](SAJC-2-86a-g003){#F3}

Exposure to environmental tobacco smoke, occupational exposure (arsenic, asbestos, chromates, chloromethyl ethers, nickel, radon), combustion-generated carcinogens, fumes and smoke from cooking stoves and high-fat diet are risk factors for lung cancer in never smokers.\[[@ref3]\] It is a well-known fact that viruses cause lung cancer in never smokers. Human Papilloma virus, Simian virus 40 and Epstein Barr viruses have also been implicated in causation of lung cancer.\[[@ref4][@ref5][@ref6]\]

These viruses cause lung cancer by multiple and complex mechanisms. Human Papilloma virus expresses viral oncoproteins E6/E7 and E5.\[[@ref4]\] Oncoprotein E7 hypermethylates and inactivate regions of P16 genes leading to uncontrolled mitosis.\[[@ref4]\] This mechanism confers resistance to Cisplatin in HPV subtype 16/18 infected lung cancer. Oncoprotein E5 phosphorylates pRB gene leading to uncontrolled cell replication and inhibiting the tumor suppressor gene p21 leading to cancer relapse.\[[@ref4]\] Simian Virus 40 DNA sequences are found in pleural mesotheliomas.\[[@ref7]\] Epstein Barr Virus (EBV) association has been found in two types of lung cancers, lymphoepithelioma-like carcinoma and squamous cell carcinoma. Lymphoepithelioma-like cancer of the lung tends to affect young never-smoker patients.\[[@ref8]\]

Hepatitis C virus (HCV) is endemic worldwide and affects 170 million people comprising 3% of the world population. The chronic inflammation caused by Hepatitis C infection is responsible for carcinogenesis.\[[@ref9]\] Since Hepatitis C virus is an emerging infection in India, its contribution to the "epidemic" of lung cancer will have long-term public health implications in the coming decades.

We draw attention to the need for multicenter studies on Indian patients with HCV infection to clarify its association with lung cancer.
